Safety and Efficacy of OMS302 in Subjects Undergoing Unilateral Cataract Extraction With Lens Replacement (CELR)
Public ClinicalTrials.gov record NCT01193127. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT01193127
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Omeros Corporation
- Industry
- Enrollment
- 223 participants
Conditions and interventions
Conditions
Interventions
- OMS302 Solution Drug
- OMS302 Mydriatic Solution Drug
- OMS302 Anti-inflammatory Solution Drug
- Balanced Salt Solution (BSS) Solution Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2010
- Primary completion
- Dec 31, 2010
- Completion
- Jan 31, 2011
- Last update posted
- Aug 27, 2014
2010 – 2011
United States locations
- U.S. sites
- 24
- U.S. states
- 16
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Chandler | Arizona | 85224 | — |
| Not listed | Glendale | Arizona | 85308 | — |
| Not listed | Little Rock | Arkansas | 72205 | — |
| Not listed | Los Angeles | California | 90013 | — |
| Not listed | Parker | Colorado | 80134 | — |
| Not listed | Largo | Florida | 33770 | — |
| Not listed | North Fort Myers | Florida | 33903 | — |
| Not listed | Panama City | Florida | 32405 | — |
| Not listed | Tamarac | Florida | 33321 | — |
| Not listed | Gurnee | Illinois | 60031 | — |
| Not listed | Gretna | Louisiana | 70056 | — |
| Not listed | Kansas City | Missouri | 64111 | — |
| Not listed | St Louis | Missouri | 63131 | — |
| Not listed | Omaha | Nebraska | 68131 | — |
| Not listed | Las Vegas | Nevada | 89135 | — |
| Not listed | Albuquerque | New Mexico | 87113 | — |
| Not listed | Rockville Centre | New York | 11570 | — |
| Not listed | Bala-Cynwyd | Pennsylvania | 19004 | — |
| Not listed | Goodlettsville | Tennessee | 37072 | — |
| Not listed | Austin | Texas | 78731 | — |
| Not listed | Houston | Texas | 77024 | — |
| Not listed | Nacogdoches | Texas | 75965 | — |
| Not listed | San Antonio | Texas | 78229 | — |
| Not listed | Salt Lake City | Utah | 84132 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01193127, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 27, 2014 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01193127 live on ClinicalTrials.gov.